NanoViricides Inc. | Mutual Funds
Mutual Funds that own NanoViricides Inc.
Vanguard Total Stock Market Index Fund
752,491
1.09%
0
0%
07/31/2018
Vanguard Extended Market Index Fund
380,907
0.55%
0
0%
07/31/2018
Fidelity Spartan Extended Market Index Fund
143,363
0.21%
0
0%
07/31/2018
Vanguard Institutional Total Stock Market Index Fund
49,787
0.07%
0
0%
07/31/2018
Vanguard Balanced Index Fund
35,421
0.05%
0
0%
07/31/2018
Fidelity Spartan Total Market Index Fund
32,620
0.05%
0
0%
07/31/2018
iShares Core S&P Total US Stock Market ETF
22,907
0.03%
0
0%
09/06/2018
Vanguard Total Stock Market Index Trust
17,500
0.03%
0
0%
07/31/2018
AXA/Lord Abbett Micro Cap Portfolio
8,270
0.01%
0
0%
03/31/2018
Vanguard Invt. Fds. ICVC - US Equity Index Fund
7,700
0.01%
0
0%
06/30/2018
| Address |
1 Controls Drive
Shelton Connecticut 06484
United States
|
|
Employees
|
- |
| Website |
http://www.nanoviricides.com |
| Updated |
07/08/2019 |
| NanoViricides, Inc. is a nano-biopharmaceutical company. The company engages in the discovery, development, and commercialization of therapeutics to advance the care of patients suffering from life-threatening viral infections. It intends to manufacture Injectable and Oral FluCide, HIVCide, Nanoviricide Eye Drops, HerpeCide, DengueCide, RabiCide as well as other drugs for pre-clinical animal studies and human clinical studies. |
